Scint-X - Structured Scintillators


Press Contact, +49 174 6069 007

Scint-X Raises SEK 22 Million in Growth Capital from NXT2B, Conor and Praktikerinvest

The Swedish company Scint-X has secured SEK 22 million equity investment. NXT2B has, as a new investor, invested 14.4 million and the present owners Conor and Praktikerinvest fulfilled the investment round. . The funds will ensure that Scint-X can continue the commercialization of its products and to build up high-volume manufacturing capacity of x-ray scintillators.

Kista, Sweden - September 03, 2013 - Scint-X, the developer of a novel and unique x-ray scintillator device based on its patented structured scintillator technology, announced that it has raised SEK 22 million in growth capital through a private placement to NXT2B, Conor and Praktikerinvest. Venture capital firm NXT2B, founded by Bengt Ågerup, is a new investor in Scint-X. 

Scint-X has its technology roots at KTH Royal Institute of Technology in Sweden. The company has developed a patented scintillator technology to serve the x-ray industry with significantly higher resolution and image quality.

The funds will be used to further develop ongoing projects with international customers and to build up high-volume manufacturing capacity in Kista, Sweden. In addition, the patented technology will be developed further.

"The investment enables us to further strengthen our leading scintillator technology base, and to build up high-volume manufacturing capacity of scintillators enabling usto take a strong position on the international digital x-ray market. We have proven our technology together with our present customers, and we are extremely happy welcoming an additional professional investor having a strong background from growth equity investments in healthcare, medical devices and specialty pharmaceutical companies. NXT2B has the industry knowledge and contacts from the medical market that will give us even further insights into our customers' needs"

"Scint-X has an innovative technology that we believe will be beneficial in several applications including medical diagnostics and Scint-X fits well into our investment focus", says Alexander Kotsinas , Partner at NXT2B and new board member at Scint-X.

For more information please visit Scint-X at or contact:
James Quinn CEO at Scint-X: 174 6069 007
Alexander Kotsinas, Partner at NXT2B:, , +46  73 500 1111

Scint-X develops and markets a technology for enhancing the performance of x-ray digital imaging detectors, based on its patented and innovative structured scintillator technique. Scint-X enables its customers to build x- ray systems with unprecedented image quality and with very high resolution.
For more information, please visit

NXT2B  is a leading venture capital/private equity firm with focus on growth equity investments in healthcare, medical devices and specialty pharmaceutical companies. NXT2B also invests in technology and consumer companies. NXT2B started in 2011 and has invested in more than 30 companies . NXT2B supports its portfolio company management teams to build market leading companies.
For more information, please visit

Praktikertjänst is Sweden's largest group of companies within the sector for private, commercially operated dental care and healthcare, where the 2,120 shareholders themselves run the practices/laboratories throughout the country. The shareholders are professionals who work as dentists, dental technicians/laboratory managers, dental hygienists, doctors, physiotherapists, psychoanalysts/psychotherapists, nurses, midwives, and others. The group also includes fifteen subsidiaries. Group sales 2011 was SEK 8.9 billion and the number of employees was 8,760.

Conor Venture Partners is a leading early-stage technology VC investing in Nordic and the Baltics. Conor invests in disruptive technologies in ICT, embedded systems, electronics, new materials and optics.

For more information, please visit
STING Capital is one of the few venture capital funds in Sweden that invests at the earliest stages of
development - even before there is a finished product or paying customers. STING Capital is a
commercial VC fund that takes big risk and expects high returns. The early-stage VC fund is often the
first external investor to offer business ideas or concepts financial support, and can invest up to SEK 4 million per business. 

For more information, please visit